William Kelly
Director of Finance/CFO bei VICARIOUS SURGICAL INC.
Vermögen: 155 870 $ am 31.03.2024
Profil
William John Kelly is currently the Chief Financial Officer & Treasurer at Vicarious Surgical, Inc. Prior to this, he was the Chief Financial Officer at Exosome Diagnostics, Inc. and held various financial positions at Repligen Corp., Haemonetics Corp., and SiteScape, Inc. He also worked as an Audit Manager at Ernst & Young LLP and Deloitte & Touche LLP.
Kelly received his undergraduate degree from the College of the Holy Cross and his graduate degree, including an MBA, from Northeastern University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
20.03.2024 | 517 841 ( 0,33% ) | 155 870 $ | 31.03.2024 |
Aktive Positionen von William Kelly
Unternehmen | Position | Beginn |
---|---|---|
VICARIOUS SURGICAL INC. | Director of Finance/CFO | 17.09.2021 |
Ehemalige bekannte Positionen von William Kelly
Unternehmen | Position | Ende |
---|---|---|
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Director of Finance/CFO | 01.01.2018 |
REPLIGEN CORPORATION | Director of Finance/CFO | 09.05.2014 |
HAEMONETICS CORPORATION | Comptroller/Controller/Auditor | 01.01.2008 |
SiteScape, Inc.
SiteScape, Inc. Packaged SoftwareTechnology Services SiteScape, Inc. provides internet communication software solutions. Its products include forum ZX, ST, IC Ecore and Zon. The company was founded in 1995 and is headquartered in Maynard, MA. | Comptroller/Controller/Auditor | 01.01.2001 |
D8 HLDG | Director of Finance/CFO | - |
Ausbildung von William Kelly
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
REPLIGEN CORPORATION | Health Technology |
HAEMONETICS CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
SiteScape, Inc.
SiteScape, Inc. Packaged SoftwareTechnology Services SiteScape, Inc. provides internet communication software solutions. Its products include forum ZX, ST, IC Ecore and Zon. The company was founded in 1995 and is headquartered in Maynard, MA. | Technology Services |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Vicarious Surgical, Inc. | |
D8 Holdings Corp.
D8 Holdings Corp. Financial ConglomeratesFinance D8 Holdings Corp. is a blank check company, which is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, focusing on regional consumer brands. The company was founded on May 6, 2020 and is headquartered in Hong Kong. | Finance |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |